Development
CME Group Inc.
CME
$271.13
$1.430.53%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 19.13% | 8.69% | 8.93% | 5.91% | 3.96% |
| Total Other Revenue | 20.20% | 13.85% | 31.50% | 35.30% | 214.38% |
| Total Revenue | 19.20% | 9.00% | 10.00% | 7.09% | 17.09% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 19.20% | 9.00% | 10.00% | 7.09% | 17.09% |
| SG&A Expenses | 9.14% | 4.68% | 7.91% | 9.56% | 3.66% |
| Depreciation & Amortization | -4.75% | -1.89% | -0.89% | -3.48% | -4.13% |
| Other Operating Expenses | -31.12% | 49.07% | 19.94% | 27.99% | -11.89% |
| Total Operating Expenses | 0.13% | 5.92% | 7.12% | 8.40% | -0.60% |
| Operating Income | 35.22% | 11.02% | 11.86% | 6.36% | 37.65% |
| Income Before Tax | 21.60% | 10.72% | 17.27% | 26.26% | 3.50% |
| Income Tax Expenses | 1.06% | 11.83% | 16.94% | 33.02% | 8.79% |
| Earnings from Continuing Operations | 27.70% | 10.39% | 17.37% | 24.30% | 2.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.70% | 10.39% | 17.37% | 24.30% | 2.03% |
| EBIT | 35.22% | 11.02% | 11.86% | 6.36% | 37.65% |
| EBITDA | 30.36% | 9.62% | 10.49% | 5.40% | 30.73% |
| EPS Basic | 27.56% | 10.30% | 17.29% | 24.20% | 3.89% |
| Normalized Basic EPS | 21.50% | 10.62% | 17.17% | 26.14% | 38.54% |
| EPS Diluted | 27.56% | 10.16% | 17.53% | 24.62% | 3.89% |
| Normalized Diluted EPS | 21.43% | 10.62% | 17.20% | 26.21% | 38.60% |
| Average Basic Shares Outstanding | 0.09% | 0.09% | 0.08% | 0.09% | 0.08% |
| Average Diluted Shares Outstanding | 0.14% | 0.09% | 0.06% | 0.04% | 0.05% |
| Dividend Per Share | 10.00% | 10.00% | 10.00% | 10.00% | 11.11% |
| Payout Ratio | -0.14% | 0.00% | -0.06% | 0.06% | -- |